(RTTNews) – Shares of commercial-stage rare disease company Centogene N.V. (CNTG) are rising more than 11% Thursday morning at $13.35. It has been trading in the range of $7.80- $28.71 in the past 52-weeks.
Centogene said today that its COVID-1nine verification kit called CentoKit-1nine is now on Amazon in Germany. CENTOGENE is the first operator to make the SARS-CoV-2 RNA verification kit to be held online in Germany.